BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22073383)

  • 1. Psychiatric comorbidity and treatment response in patients with tuberous sclerosis complex.
    Chung TK; Lynch ER; Fiser CJ; Nelson DA; Agricola K; Tudor C; Franz DN; Krueger DA
    Ann Clin Psychiatry; 2011 Nov; 23(4):263-9. PubMed ID: 22073383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex.
    Muzykewicz DA; Newberry P; Danforth N; Halpern EF; Thiele EA
    Epilepsy Behav; 2007 Dec; 11(4):506-13. PubMed ID: 17936687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavior problems in children with tuberous sclerosis complex and parental stress.
    Kopp CM; Muzykewicz DA; Staley BA; Thiele EA; Pulsifer MB
    Epilepsy Behav; 2008 Oct; 13(3):505-10. PubMed ID: 18602868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbid personality disorder and treatment use in a community sample of youths: a 20-year follow-up.
    Kasen S; Cohen P; Skodol AE; First MB; Johnson JG; Brook JS; Oldham JM
    Acta Psychiatr Scand; 2007 Jan; 115(1):56-65. PubMed ID: 17201867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopathology in tuberous sclerosis: an overview and findings in a population-based sample of adults with tuberous sclerosis.
    Raznahan A; Joinson C; O'Callaghan F; Osborne JP; Bolton PF
    J Intellect Disabil Res; 2006 Aug; 50(Pt 8):561-9. PubMed ID: 16867063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal follow up of primary insomnia patients in a psychiatric clinic.
    Fong SY; Wing YK
    Aust N Z J Psychiatry; 2007 Jul; 41(7):611-7. PubMed ID: 17558624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.
    Pliszka SR
    J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity and temporal ordering of alcohol use disorders and other psychiatric disorders: results from a Danish register-based study.
    Flensborg-Madsen T; Mortensen EL; Knop J; Becker U; Sher L; Grønbaek M
    Compr Psychiatry; 2009; 50(4):307-14. PubMed ID: 19486728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of abuse and gender on psychopathology, behavioral disturbance, and psychotropic medication count for youth in residential treatment.
    Badura Brack A; Huefner JC; Handwerk ML
    Am J Orthopsychiatry; 2012 Oct; 82(4):562-72. PubMed ID: 23039354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric diagnosis and psychotropic medication prescription patterns in a mental hospital-based child and adolescent psychiatric service in Nigeria.
    Bakare MO; Igwe MN; Odinka PC; Iteke O
    J Health Care Poor Underserved; 2011 Aug; 22(3):751-5. PubMed ID: 21841276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stressor-related disorders in tuberous sclerosis.
    Boronat S; Van Eeghen AM; Shinnick JE; Newberry P; Thiele EA
    Ann Clin Psychiatry; 2013 Nov; 25(4):243-9. PubMed ID: 23926580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex.
    D'Agati E; Moavero R; Cerminara C; Curatolo P
    J Child Neurol; 2009 Oct; 24(10):1282-7. PubMed ID: 19805824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].
    Grolleau A; Cougnard A; Bégaud B; Verdoux H
    Encephale; 2008 Sep; 34(4):352-9. PubMed ID: 18922237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-adaptive disabilities.
    Calles JL
    Pediatr Clin North Am; 2011 Feb; 58(1):189-203, xii. PubMed ID: 21281856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidity in young adults with a clinical diagnosis of Asperger syndrome.
    Lugnegård T; Hallerbäck MU; Gillberg C
    Res Dev Disabil; 2011; 32(5):1910-7. PubMed ID: 21515028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity in children and adolescent psychiatry.
    Burgić-Radmanović M; Burgić S
    Psychiatr Danub; 2010 Jun; 22(2):298-300. PubMed ID: 20562768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of psychiatric comorbidity in patients with refractory epilepsy.
    Karouni M; Henning O; Larsson PG; Johannessen SI; Johannessen Landmark C
    Epilepsy Behav; 2013 Oct; 29(1):77-81. PubMed ID: 23939032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and comorbidity of common mental disorders in primary care.
    Roca M; Gili M; Garcia-Garcia M; Salva J; Vives M; Garcia Campayo J; Comas A
    J Affect Disord; 2009 Dec; 119(1-3):52-8. PubMed ID: 19361865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
    Gum AM; King-Kallimanis B; Kohn R
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.